Article content material

Cannabix is creating Marijuana Breathalyzer gadgets to provide regulation enforcement and employers a device to reinforce public security

Article content material

VANCOUVER, British Columbia, Nov. 07, 2022 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana breathalyzer gadgets for regulation enforcement and the office stories that it has entered right into a memorandum of understanding with the Warren County, Pennsylvania, District Attorney’s workplace to pilot the Company’s expertise for detection of ∆9-tetrahydrocannabinol (“THC”) and in human breath. The Company’s proprietary breath seize and laboratory-based marijuana detection tools (as described beneath) shall be used to gather and ensure THC in breath samples. Cannabix plans to provide 2 handheld Breath Collection Units (BCU) to Warren police earlier than the tip of the 12 months and such gadgets shall be utilized in Warren County on the discretion of its police drive for as much as 3 months or longer. The Cannabix BCU can be utilized to gather time of cease breath samples instantly upon suspicion of hashish use by a driver. Field Samples collected utilizing the BCU by Warren police (and Drug Recognition Experts) shall be processed at a chosen laboratory utilizing proprietary “MS Breath Sampler” {hardware}.

Article content material

Article content material

Warren County District Attorney Robert C. Greene, acknowledged the next, “Marijuana use is here and has been for decades. Pennsylvania (PA) has legalized the medical use of marijuana and recreational adult use is right around the corner. Every state surrounding Pennsylvania has legalized medical marijuana and more importantly, Warren County borders the State of New York which has legalized recreational use. The goal is to keep Warren County citizens safe from impaired drivers.

Currently, in Pennsylvania, an individual cannot drive if there is ANY marijuana metabolite in their blood. Therefore, if an individual is completely sober, but legally used marijuana in the weeks prior to driving on PA roads, they are driving illegally according to PA law and can be arrested and charged with Driving Under the Influence, see 75 Pa.C.S.A.§3802(d)(1)(iii). And yes, this happens every day in Pennsylvania.

Article content

We are excited about the opportunity to work with Cannabix to assist in testing a breath test device that can detect if an individual has smoked marijuana in the past 2-3 hours. If this device is proven to be reliable in PA Courts, this could be a game changer in keeping our roads safer with new legislation and at the same time, not infringe on citizens’ rights who use marijuana legally and still want to be able to drive a vehicle. Warren County looks forward to working with Cannabix on the Pilot Program.”

Rav Mlait, CEO of Cannabix acknowledged, “Cannabix’s collaboration with Warren County will help us in our efforts to gather critical real-world data using our technology and methods. The Warren County District Attorney’s office has an unwavering commitment to keeping its citizens safe as laws surrounding marijuana consumption evolve and we commend their leadership and participation in helping advance cutting-edge cannabis breath technology. We are seeking additional collaborators and welcome such interest.”

Article content material

Current types of testing for marijuana use can determine THC starting from minutes to days after precise use, making it not possible to indicate the distinction between the 2. Studies¹ have proven that breath is a greater indicator of impairment than saliva, blood, or urine as a result of THC is current in breath for a comparatively brief time frame (1-3 hours) after consumption; whereas, it’s excreted at detectable ranges in different physique fluids for a lot of hours, days, and even weeks after smoking. This brief time interval of detection in breath aligns with the height impairment window.

The Company’s handheld Breath Collection Unit (“BCU”, Fig. 1) and newly developed laboratory “MS Breath Sampler” (Fig. 2) are getting used collectively to offer a brand new methodology for drug detection that enhances gold-standard mass spectrometry (MS) and considerably simplifies laboratory evaluation strategies, reduces pattern turnaround instances (thus minimizing working prices), whereas sustaining delicate, exact outcomes. It must be famous the BCU can also be being utilized in live performance with the Cannabix FAIMS Detection Unit (a separate system, beneath growth, not a part of this pilot, which is being developed as a transportable system able to each breath assortment and analyses within the discipline).

Article content material

The Cannabix BCU will present fast and nonintrusive breath pattern assortment and straightforward evaluation with no pattern preparation wanted in a lab setting utilizing the Company’s “MS Breath Sampler” {hardware}. In comparability, present and legacy breath and saliva testing procedures require a number of pattern extraction and preparation steps previous to evaluation, and evaluation itself can take from 1 – 3 hours per pattern. This is pricey and impractical. Also, present and legacy breath and saliva testing procedures are likely to have inefficient, time-consuming assortment strategies, and recoveries are nonetheless usually poor. Cannabix has developed distinctive approaches to breath testing that may cut back prices and make operations and processes much more environment friendly.

Article content material

Readers ought to be aware, though the Company has achieved proof of idea prototype for its BCU and MS Breath Sampler, the testing methodology and system continues to be within the preapproval stage and accordingly the Company will not be at the moment making any categorical or implied claims that the expertise will proceed to business use.

_{(1) Olla P, Ishraque MT, Bartol S. 2020. Evaluation of Breath and Plasma Tetrahydrocannabinol Concentration Trends Postcannabis Exposure in Medical Cannabis Patients. Cannabis and Cannabinoid Res.; 99-104.}

_{Himes S. et al. 2013. Cannabinoids in Exhaled Breath following Controlled Administration of Smoked Cannabis. Clinical Chemistry; 1780–1789.}

_{Beck O, Sandqvist S, Dubbelboer I, Franck J. 2011. Detection of delta9-tetrahydrocannabinol in exhaled breath collected from hashish customers. J Anal Toxicol; 35:541– 4.}

Article content material

About Cannabix Technologies Inc.

Cannabix Technologies Inc. is a developer of marijuana breathalyzer applied sciences for regulation enforcement and the office. Cannabix is working to develop drug-screening gadgets that may detect THC – the psychoactive part of marijuana that causes impairment utilizing breath samples. Breath testing for THC would permit employers and regulation enforcement to determine current marijuana use that higher aligns with impairment. Cannabix gadgets are within the superior prototype and pre-clinical testing stage.

We search Safe Harbor.

On behalf of the Board of Directors

“Rav Mlait”

CEO
Cannabix Technologies Inc.

For additional data, contact the Company at info@cannabixtechnologies.com

Article content material

The CSE has not reviewed and doesn’t settle for accountability for the adequacy or accuracy of this launch.

Cautionary Statement Regarding Forward-Looking Statements

This press launch accommodates forward-looking data that entails numerous dangers and uncertainties relating to future occasions. Such forward-looking data can embody with out limitation statements primarily based on present expectations involving various dangers and uncertainties and are usually not ensures of future efficiency of the Company, reminiscent of last growth of a business or prototype product(s), profitable trial or pilot of firm applied sciences, no assurance that business gross sales of any sort truly materialize; no assurance the Company may have ample funds to finish product growth. There are quite a few dangers and uncertainties that would trigger precise outcomes and the Company’s plans and targets to vary materially from these expressed within the forward-looking data, together with: (i) opposed market circumstances; (ii) dangers relating to safety of proprietary expertise; (iii) the flexibility of the Company to finish financings; (iv) the flexibility of the Company to develop and market its future product; and (v) dangers relating to authorities regulation, managing and sustaining progress, the impact of opposed publicity, litigation, competitors and different components which can be recognized infrequently within the Company’s public bulletins and filings. There isn’t any assurance that its growth of marijuana breathalyzer expertise will present any profit to the Company, and no assurance that any proposed new merchandise shall be constructed, shall be profitable in beta testing or medical trials. There isn’t any assurance that present “patent pending” applied sciences licensed by the Company will obtain patent standing by regulatory authorities. The Company will not be at the moment promoting business breathalyzers. Actual outcomes and future occasions might differ materially from these anticipated in such data. These and all subsequent written and oral forward-looking data are primarily based on estimates and opinions of administration on the dates they’re made and are expressly certified of their entirety by this discover. Except as required by regulation, the Company doesn’t intend to replace these forward-looking statements.

A photograph accompanying this announcement is accessible at https://www.globenewswire.com/NewsRoom/AttachmentNg/d649e2e5-8634-4643-b56c-8a87bddb1cf7